Phospholipid binding of antiphospholipid antibodies and placental anticoagulant protein

69Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.
Get full text

Abstract

We evaluated the interaction of antiphospholipid antibodies (aPL) with placental anticoagulant protein I (PAP I), a calcium-dependent phospholipid binding protein which may act as a natural anticoagulant. Clotting assays showed additive prolongation of clotting times with aPL and PAP I. ELISA and vesicle phospholipid binding studies showed PAP I inhibition of aPL binding to phospholipid but no inhibition of PAP I-phospholipid binding by aPL. aPL and PAP I interact additively in anticoagulant activity in in vitro clotting systems and compete for phospholipid in ELISA system. These data support the hypotheses that aPL and PAP I may recognize similar phospholipid epitopes and that in vivo interaction may occur. © 1992 Plenum Publishing Corporation.

Cite

CITATION STYLE

APA

Sammaritano, L. R., Gharavi, A. E., Soberano, C., Levy, R. A., & Lockshin, M. D. (1992). Phospholipid binding of antiphospholipid antibodies and placental anticoagulant protein. Journal of Clinical Immunology, 12(1), 27–35. https://doi.org/10.1007/BF00918270

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free